• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

僵人综合征谱系障碍患者的认知和情绪概况

Cognitive and Mood Profiles Among Patients With Stiff Person Syndrome Spectrum Disorders.

作者信息

Chan Carol K, Pimentel Maldonado Daniela A, Wang Yujie, Obando Danielle, Hughes Abbey J, Newsome Scott D

机构信息

Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, MD, United States.

Department of Neurology, Johns Hopkins University, Baltimore, MD, United States.

出版信息

Front Neurol. 2022 May 27;13:865462. doi: 10.3389/fneur.2022.865462. eCollection 2022.

DOI:10.3389/fneur.2022.865462
PMID:35693022
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9184450/
Abstract

UNLABELLED

An emerging body of evidence suggests that changes in cognitive and emotional function are common aspects of stiff person spectrum disorders (SPSD). We sought to examine the pattern of cognitive impairment and psychiatric symptoms in SPSD.

METHODS

A retrospective review of medical records was conducted for patients seen at the Johns Hopkins Stiff Person Syndrome (SPS) center from 1997 to January 1st, 2020. Individuals who had received formal cognitive testing as part of routine clinical care for patient-reported cognitive changes were included. Demographics, prevalence of cognitive impairment, psychoactive medication use, and clinically significant psychiatric symptoms were described.

RESULTS

Out of 205 patients screened, 20 completed cognitive testing (75% female, mean age 47.4 years). The most common domains of impairment were verbal learning and recall memory ( = 14, 70%), verbal fluency ( = 10, 50%), processing speed ( = 8, 40%), and attention ( = 8, 40%). 9/11 patients assessed for depression reported clinically significant symptoms, and 4/9 patients assessed for anxiety reported clinically significant symptoms.

CONCLUSIONS

Screening for cognitive impairment in SPSD should utilize testing that assesses verbal learning and recall, phonemic verbal fluency, attention, and processing speed. Moreover, it is important to evaluate for co-existing depression and anxiety symptoms, as these are common in SPSD.

摘要

未标注

越来越多的证据表明,认知和情绪功能的变化是僵人谱系障碍(SPSD)的常见特征。我们试图研究SPSD中的认知障碍模式和精神症状。

方法

对1997年至2020年1月1日在约翰·霍普金斯僵人综合征(SPS)中心就诊的患者的病历进行回顾性研究。纳入那些因患者报告的认知变化而接受正式认知测试作为常规临床护理一部分的个体。描述了人口统计学、认知障碍患病率、精神活性药物使用情况以及具有临床意义的精神症状。

结果

在筛查的205名患者中,20名完成了认知测试(75%为女性,平均年龄47.4岁)。最常见的受损领域是言语学习和回忆记忆(n = 14,70%)、言语流畅性(n = 10,50%)、处理速度(n = 8,40%)和注意力(n = 8,40%)。接受抑郁症评估的11名患者中有9名报告了具有临床意义的症状,接受焦虑症评估的9名患者中有4名报告了具有临床意义的症状。

结论

SPSD的认知障碍筛查应采用评估言语学习和回忆、音素言语流畅性、注意力和处理速度的测试。此外,评估并存的抑郁和焦虑症状很重要,因为这些在SPSD中很常见。

相似文献

1
Cognitive and Mood Profiles Among Patients With Stiff Person Syndrome Spectrum Disorders.僵人综合征谱系障碍患者的认知和情绪概况
Front Neurol. 2022 May 27;13:865462. doi: 10.3389/fneur.2022.865462. eCollection 2022.
2
Prevalence of non-neurological autoantibodies and related comorbidities in stiff person spectrum disorders.僵人谱系障碍中非神经自身抗体及相关共病的患病率。
Front Neurol. 2023 Nov 22;14:1289460. doi: 10.3389/fneur.2023.1289460. eCollection 2023.
3
The many faces of gastrointestinal dysfunction in stiff person syndrome spectrum disorders.僵人综合征谱系障碍中胃肠功能障碍的多种表现
Front Neurol. 2023 Oct 6;14:1273256. doi: 10.3389/fneur.2023.1273256. eCollection 2023.
4
COVID-19 risk factors and outcomes in individuals with stiff person syndrome spectrum disorders before and after omicron.奥密克戎变异株前后僵人综合征谱障碍患者的 COVID-19 风险因素和结局。
Orphanet J Rare Dis. 2024 Sep 27;19(1):356. doi: 10.1186/s13023-024-03357-w.
5
Therapeutic plasma exchange in the management of stiff person syndrome spectrum disorders: a case series and review of the literature.治疗性血浆置换在僵人综合征谱系障碍管理中的应用:病例系列及文献综述
Ther Adv Neurol Disord. 2023 Jul 24;16:17562864231180736. doi: 10.1177/17562864231180736. eCollection 2023.
6
Cognitive correlates of verbal memory and verbal fluency in schizophrenia, and differential effects of various clinical symptoms between male and female patients.精神分裂症患者的言语记忆和言语流畅性的认知相关性,以及不同性别患者各种临床症状的差异影响。
Schizophr Res. 2013 Jun;147(1):81-85. doi: 10.1016/j.schres.2013.03.014. Epub 2013 Apr 8.
7
Expanding clinical profiles and prognostic markers in stiff person syndrome spectrum disorders.扩展僵硬人综合征谱障碍的临床特征和预后标志物。
J Neurol. 2024 Apr;271(4):1861-1872. doi: 10.1007/s00415-023-12123-0. Epub 2023 Dec 11.
8
Pragmatic Treatment of Stiff Person Spectrum Disorders.僵人谱系障碍的实用治疗
Mov Disord Clin Pract. 2018 Jul 19;5(4):394-401. doi: 10.1002/mdc3.12629. eCollection 2018 Jul-Aug.
9
[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].[一种用于评估精神分裂症认知功能的新工具的价值:精神分裂症认知功能简短评估量表(BACS)]
Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9.
10
Differential Effect of Demographics, Processing Speed, and Depression on Cognitive Function in 755 Non-demented Community-dwelling Elderly Individuals.755名非痴呆社区居住老年人的人口统计学、加工速度和抑郁对认知功能的差异影响
Cogn Behav Neurol. 2019 Dec;32(4):236-246. doi: 10.1097/WNN.0000000000000211.

引用本文的文献

1
Expanding clinical profiles and prognostic markers in stiff person syndrome spectrum disorders.扩展僵硬人综合征谱障碍的临床特征和预后标志物。
J Neurol. 2024 Apr;271(4):1861-1872. doi: 10.1007/s00415-023-12123-0. Epub 2023 Dec 11.
2
Stiff Person Spectrum Disorders-An Update and Outlook on Clinical, Pathophysiological and Treatment Perspectives.僵人谱系障碍——临床、病理生理及治疗前景的最新进展与展望
Biomedicines. 2023 Sep 10;11(9):2500. doi: 10.3390/biomedicines11092500.
3
Therapies in Stiff-Person Syndrome: Advances and Future Prospects Based on Disease Pathophysiology.

本文引用的文献

1
Brain and Muscle Metabolic Changes by FDG-PET in Stiff Person Syndrome Spectrum Disorders.18F-氟代脱氧葡萄糖正电子发射断层显像评估僵人综合征谱系障碍患者脑和肌肉的代谢变化
Front Neurol. 2021 Sep 17;12:692240. doi: 10.3389/fneur.2021.692240. eCollection 2021.
2
Brain mechanisms underlying neuropsychiatric symptoms in Alzheimer's disease: a systematic review of symptom-general and -specific lesion patterns.阿尔茨海默病神经精神症状的大脑机制:症状一般和特定病变模式的系统综述。
Mol Neurodegener. 2021 Jun 7;16(1):38. doi: 10.1186/s13024-021-00456-1.
3
Clinical spectrum of high-titre GAD65 antibodies.
僵人综合征的治疗:基于疾病病理生理学的进展和未来前景。
Neurol Neuroimmunol Neuroinflamm. 2023 Apr 14;10(3). doi: 10.1212/NXI.0000000000200109. Print 2023 May.
4
Stiff person syndrome spectrum disorders; more than meets the eye.僵人综合征谱障碍;比想象的更复杂。
J Neuroimmunol. 2022 Aug 15;369:577915. doi: 10.1016/j.jneuroim.2022.577915. Epub 2022 Jun 12.
高滴度GAD65抗体的临床谱
J Neurol Neurosurg Psychiatry. 2021 Feb 9;92(6):645-54. doi: 10.1136/jnnp-2020-325275.
4
Stiff-Person Syndrome and Psychiatric Comorbidities: A Systematic Review.僵人综合征与精神科共病:一项系统综述
J Acad Consult Liaison Psychiatry. 2021 Jan-Feb;62(1):3-13. doi: 10.1016/j.psym.2020.08.005. Epub 2020 Sep 15.
5
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study.抗胆碱能药物暴露与痴呆风险:一项巢式病例对照研究。
JAMA Intern Med. 2019 Aug 1;179(8):1084-1093. doi: 10.1001/jamainternmed.2019.0677.
6
Worse cognitive performance predicts increased anxiety and depressive symptoms in patients with Parkinson's disease: A bidirectional analysis.认知功能较差预示帕金森病患者焦虑和抑郁症状增加:一项双向分析。
Neuropsychology. 2019 Jan;33(1):35-46. doi: 10.1037/neu0000498. Epub 2018 Oct 18.
7
GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia.GABA 能抑制性神经元作为精神分裂症认知障碍的治疗靶点。
Acta Pharmacol Sin. 2018 May;39(5):733-753. doi: 10.1038/aps.2017.172. Epub 2018 Mar 22.
8
Benzodiazepine use and cognitive decline in the elderly.老年人使用苯二氮䓬类药物与认知功能衰退
Am J Health Syst Pharm. 2018 Jan 1;75(1):e6-e12. doi: 10.2146/ajhp160381.
9
Reduced GABA levels correlate with cognitive impairment in patients with relapsing-remitting multiple sclerosis.复发缓解型多发性硬化症患者的 GABA 水平降低与认知障碍相关。
Eur Radiol. 2018 Mar;28(3):1140-1148. doi: 10.1007/s00330-017-5064-9. Epub 2017 Oct 6.
10
Treatment Options in Alzheimer´s Disease: The GABA Story.阿尔茨海默病的治疗选择:GABA的故事
Curr Pharm Des. 2015;21(34):4960-71. doi: 10.2174/1381612821666150914121149.